Financhill
Back

Oragenics 10K Form

Sell
30

OGEN
Oragenics

Last Price:
0.31
Seasonality Move:
6.39%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive OGEN News And Ratings

See the #1 stock for the next 7 days that we like better than OGEN

OGEN Financial Statistics

Sales & Book Value

Annual Sales: $131.52K
Cash Flow: $-1.54M
Price / Cash Flow: 0
Annual Sales: $-0.05
Price / Book: 0

Profitability

EPS (TTM): -7.54000
Net Income (TTM): $-19.52M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Oragenics Earnings Forecast

Key Oragenics Financial Ratios

  • The Selling, General & Administrative Expenses for OGEN have been equal to 3,406.03% of Gross Profit Margin.
  • The Interest Expense is -0.15% of Operating Income.
  • Per Share Earnings over the last 21 years have been positive in 15 years.

Oragenics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Health Care
Current Symbol: OGEN
CUSIP: 684023
Website: oragenics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

OGEN Technical Analysis vs Fundamental Analysis

Sell
30
Oragenics (OGEN) is a Sell

Is Oragenics a Buy or a Sell?

  • Oragenics stock is rated a Sell
    The current Oragenics [OGEN] share price is $0.32. The Score for OGEN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.